angiotensin ii has been researched along with ginsenoside rb1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azonpi, A; Bahem, R; Caballero-George, C; Hoffmann, A; Vanderheyden, P | 1 |
He, C; Li, P; Su, H; Tian, K; Wan, JB; Zhang, XJ | 1 |
Du, W; Li, X; Xiao, X; Zhang, F; Zhang, S; Zhang, Y; Zhu, M | 1 |
3 other study(ies) available for angiotensin ii and ginsenoside rb1
Article | Year |
---|---|
Modulation of Calcium Signaling of Angiotensin AT1, Endothelin ETA, and ETB Receptors by Silibinin, Quercetin, Crocin, Diallyl Sulfides, and Ginsenoside Rb1.
Topics: Allyl Compounds; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Calcium Signaling; Carotenoids; CHO Cells; Cricetinae; Cricetulus; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Ginsenosides; Humans; Quercetin; Receptors, Angiotensin; Receptors, Endothelin; Silybin; Silymarin; Sulfides | 2015 |
Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Apoptosis; Disease Models, Animal; Enzyme Activators; Extracellular Matrix; Ginsenosides; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Severity of Illness Index; Signal Transduction; Vascular Remodeling | 2015 |
Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association.
Topics: Aconitine; Angiotensin II; Animals; Benzofurans; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Drugs, Chinese Herbal; Ginsenosides; Heart Failure; Isoflavones; Male; Medicine, Chinese Traditional; Quality Control; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2018 |